News for hackers. Stuff that matters.
Re:British Regulator Urges Home Births Over Hospitals for Un... by refurb on Monday December 15, 2014 @07:47PM (#8755369)
“Yes, it’s a very expensive way to deliver healthy babies to healthy women,” Dr. Baker said about hospital births. “Saving money is not a crime.”

This is not a knock against the UK or US healthcare systems at all.

What worries me about this type of thinking is that you're looking at the cost/benefit in the aggregate. Of course, when you're running a national health system you have to. However, this is also happening in the US (the biggest US insurance companies cover 30M+ lives).

You can describe the cost/benefits overall, but it's (mostly) impossible to at the individual level. Sure the average overall survival for an expensive cancer drug might only be 6 months, but if you look at the data you'd likely see that the range if 15 days to 3 years.

Health authorities might make the call that 6 months of additional life isn't work $XX,XXX dollars, but for some of the patients whose life is extended 2-3 years, it certainly is worth it. But in the end, the call is made to not fund the drug.

I have no idea how to solve this issue. I think linking outcome with genetic information is super helpful (it's already being used), but dam, there are a lot of folks out there that could have been helped, but won't be.

Re:British Regulator Urges Home Births Over Hospitals for Un... by lotsofmangos on Monday December 15, 2014 @08:49PM (#8755513)
NICE is not perfect, but it is not bad at this problem.

Triage is not fun, but even with infinite money it is still necessary, and with finite money it has to be coldly pragmatic.

So NICE has a standard limit of £20,000 per QALY, or up to £30,000 per QALY, if certain extenuating conditions are met.

A QALY being: "A measure of the state of health of a person or group in which the benefits, in terms of length of life, are adjusted to reflect the quality of life. One QALY is equal to 1 year of life in perfect health. QALYs are calculated by estimating the years of life remaining for a patient following a particular treatment or intervention and weighting each year with a quality of life score (on a zero to 1 scale). It is often measured in terms of the person's ability to perform the activities of daily life, freedom from pain and mental disturbance."

Re:British Regulator Urges Home Births Over Hospitals for Un... by refurb on Monday December 15, 2014 @11:29PM (#8755854)
The NICE system is a good implementation of rating cost-effectiveness, but it still has the aggregation issue.

If NICE determines that a drug isn't cost-effective, no one gets it (unless you pay out of pocket), regardless if it would have helped that individual patient.